Definium Therapeutics, Inc. (DFTX)
39.28
+0.47
(+1.21%)
USD |
NASDAQ |
Sep 21, 16:00
39.27
-0.01
(-0.03%)
After-Hours: 20:00
Definium Therapeutics EPS Diluted (TTM) : -3.439 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.439 |
| March 31, 2026 | -2.503 |
| December 31, 2025 | -2.069 |
| September 30, 2025 | -1.972 |
| June 30, 2025 | -1.464 |
| March 31, 2025 | -1.044 |
| December 31, 2024 | -1.907 |
| September 30, 2024 | -2.085 |
| June 30, 2024 | -2.262 |
| March 31, 2024 | -2.935 |
| December 31, 2023 | -2.450 |
| September 30, 2023 | -1.987 |
| June 30, 2023 | -2.099 |
| March 31, 2023 | -1.944 |
| December 31, 2022 | -1.948 |
| September 30, 2022 | -2.485 |
| June 30, 2022 | -11.13 |
| March 31, 2022 | -12.18 |
| December 31, 2021 | -12.10 |
| September 30, 2021 | -12.11 |
| June 30, 2021 | -3.368 |
| March 31, 2021 | -2.095 |
| Date | Value |
|---|---|
| December 31, 2020 | -2.055 |
| September 30, 2020 | -2.991 |
| June 30, 2020 | -2.941 |
| March 31, 2020 | -3.034 |
| August 31, 2019 | -2.860 |
| May 31, 2019 | -1.861 |
| February 28, 2019 | -2.197 |
| November 30, 2018 | -2.678 |
| August 31, 2018 | -3.275 |
| May 31, 2018 | -4.522 |
| February 28, 2018 | -5.554 |
| November 30, 2017 | -5.509 |
| August 31, 2017 | -6.363 |
| May 31, 2017 | -4.499 |
| February 28, 2017 | -2.718 |
| November 30, 2016 | -1.810 |
| August 31, 2016 | 0.00 |
| May 31, 2016 | 0.00 |
| February 29, 2016 | 0.00 |
| November 30, 2015 | 0.00 |
| August 31, 2015 | 0.00 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Enliven Therapeutics, Inc. | -1.668 |
| Cocrystal Pharma, Inc. | -0.7587 |
| CNBX Pharmaceuticals, Inc. | -0.0006 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.1604 |